Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × PM 01183 × Endocrine × Clear all

Phase

Status

Completed 2 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1 Adenoma, Islet Cell 1

Interventions

somapacitan 1 irinotecan sucrosofate 1 PM 01183 1 Injections 1 Fluorodeoxyglucose F18 1 Diagnostic Self Evaluation 1 Carboplatin 1 Cabergoline 1 Bed Rest 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07121478 2025-10-01

Patients With High-grade Pancreatic Neuroendocrine Tumors

National Cancer Center, Korea

Phase 2 Enrolling by invitation

Adenoma, Islet Cell, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡